A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Purpose

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Conditions

  • Smoking
  • Smoking Cessation
  • Smoking Reduction
  • Smoking Habit
  • Smoking Behaviors
  • Smoking, Tobacco
  • Smoking, Cigarette
  • Smoking (Tobacco) Addiction
  • Tobacco Use
  • Tobacco Smoking

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Adult (aged >18 years) MSK patients as per the EHR - Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database - Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form - Must be English-speaking in the EHR - Must be reachable by phone as per self-report - Must have Wi-Fi available at home as per self-report

Exclusion Criteria

  • Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

Study Design

Phase
N/A
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Prevention
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
MSK Participants who are current smokers 		10 MSK participants who are current smokers and receiving tobacco treatment will be enrolled.
  • Other: Indoor Air Quality Monitor AirGradient ONE
    Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.

Recruiting Locations

Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey 07920
Contact:
Jamie Ostroff, PhD
646-888-0041

Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey 07748
Contact:
Jamie Ostroff, PhD
646-888-0041

Memorial Sloan Kettering Bergen (Consent only)
Montvale, New Jersey 07645
Contact:
Jaime Ostroff, PhD
646-888-0041

Memorial Sloan Kettering Suffolk-Commack (Consent only)
Commack, New York 11725
Contact:
Jamie Ostroff, PhD
646-888-0041

Memorial Sloan Kettering Westchester (Consent only)
Harrison, New York 10604
Contact:
Jamie Ostroff, PhD
646-888-0041

Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
Contact:
Jamie Ostroff, PhD
646-888-0041

Memorial Sloan Kettering Nassau (Consent only)
Uniondale, New York 11553
Contact:
Jamie Ostroff, PhD
646-888-0041

More Details

NCT ID
NCT06693700
Status
Recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Study Contact

Jamie Ostroff, PhD
646-888-0041
ostroffj@MSKCC.ORG

For help using this page: trialstoday@researchmatch.org or call 855-514-7001

ResearchMatch is funded in part by the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, led by the NIH’s National Center for Advancing Translational Sciences (NCATS), grants UL1TR000445 and 1U54RR032646-01, and grant U24TR001579 from NCATS and the National Library of Medicine. The content of this website is solely the responsibility of ResearchMatch and Vanderbilt University and does not necessarily represent the official views of the NIH, NCATS, or NLM.

Vanderbilt University Medical Center